Composición para reducir la opacidad de la piel

Un uso no terapéutico de una composición para la reducción de la opacidad de la piel, comprendiendo la composición un adenosín-monofosfato o una sal del mismo en una proporción de 1% a 10% en peso sobre la base de la cantidad total de la composición, en el que la composición comprende además un éste...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yoshino, Noboru, Tanaka, Hideo, Harano, Fumiki, Wakamatsu, Kosaburo, Kawamura, Mitsuaki, Kawabata, Shigekatsu, Tanaka, Masahiko, Shinohara, Shigeo, Furuta, Yasuo, Kamimura, Junko
Format: Patent
Sprache:spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Yoshino, Noboru
Tanaka, Hideo
Harano, Fumiki
Wakamatsu, Kosaburo
Kawamura, Mitsuaki
Kawabata, Shigekatsu
Tanaka, Masahiko
Shinohara, Shigeo
Furuta, Yasuo
Kamimura, Junko
description Un uso no terapéutico de una composición para la reducción de la opacidad de la piel, comprendiendo la composición un adenosín-monofosfato o una sal del mismo en una proporción de 1% a 10% en peso sobre la base de la cantidad total de la composición, en el que la composición comprende además un éster de poligliceril-ácido graso, un ácido alcanoil-láctico o una sal del mismo, un copolímero de ácido acrílico-metacrilato de alquilo, agua y un aceite, y se formula en una emulsión O/W. The present invention provides a cosmetic composition that can effectively improve melasma and a cosmetic composition that can effectively reduce skin dullness. The cosmetic composition for improving melasma comprises a purine nucleic acid-related substance and a cosmetically acceptable carrier, and exhibits an excellent melasma improving effect due to the action of the purine nucleic acid-related substance contained. The cosmetic composition for reducing skin dullness comprises a purine nucleic acid-related substance and a cosmetically acceptable carrier, and exhibits an excellent effect of reducing skin dullness due to the action of the purine nucleic acid-related substance contained.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2633340TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2633340TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2633340TT33</originalsourceid><addsrcrecordid>eNrjZDBwzs8tyC_OTM48vDlPoSCxKFGhKDWlNDmzSCEnUSG_IDE5MyUxRSElFcQtyEzN4WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcVADal5qSXxrsFGZsbGxiYGISHGxsSoAQCE9CvB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Composición para reducir la opacidad de la piel</title><source>esp@cenet</source><creator>Yoshino, Noboru ; Tanaka, Hideo ; Harano, Fumiki ; Wakamatsu, Kosaburo ; Kawamura, Mitsuaki ; Kawabata, Shigekatsu ; Tanaka, Masahiko ; Shinohara, Shigeo ; Furuta, Yasuo ; Kamimura, Junko</creator><creatorcontrib>Yoshino, Noboru ; Tanaka, Hideo ; Harano, Fumiki ; Wakamatsu, Kosaburo ; Kawamura, Mitsuaki ; Kawabata, Shigekatsu ; Tanaka, Masahiko ; Shinohara, Shigeo ; Furuta, Yasuo ; Kamimura, Junko</creatorcontrib><description>Un uso no terapéutico de una composición para la reducción de la opacidad de la piel, comprendiendo la composición un adenosín-monofosfato o una sal del mismo en una proporción de 1% a 10% en peso sobre la base de la cantidad total de la composición, en el que la composición comprende además un éster de poligliceril-ácido graso, un ácido alcanoil-láctico o una sal del mismo, un copolímero de ácido acrílico-metacrilato de alquilo, agua y un aceite, y se formula en una emulsión O/W. The present invention provides a cosmetic composition that can effectively improve melasma and a cosmetic composition that can effectively reduce skin dullness. The cosmetic composition for improving melasma comprises a purine nucleic acid-related substance and a cosmetically acceptable carrier, and exhibits an excellent melasma improving effect due to the action of the purine nucleic acid-related substance contained. The cosmetic composition for reducing skin dullness comprises a purine nucleic acid-related substance and a cosmetically acceptable carrier, and exhibits an excellent effect of reducing skin dullness due to the action of the purine nucleic acid-related substance contained.</description><language>spa</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS ; SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS ; SUGARS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170920&amp;DB=EPODOC&amp;CC=ES&amp;NR=2633340T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20170920&amp;DB=EPODOC&amp;CC=ES&amp;NR=2633340T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Yoshino, Noboru</creatorcontrib><creatorcontrib>Tanaka, Hideo</creatorcontrib><creatorcontrib>Harano, Fumiki</creatorcontrib><creatorcontrib>Wakamatsu, Kosaburo</creatorcontrib><creatorcontrib>Kawamura, Mitsuaki</creatorcontrib><creatorcontrib>Kawabata, Shigekatsu</creatorcontrib><creatorcontrib>Tanaka, Masahiko</creatorcontrib><creatorcontrib>Shinohara, Shigeo</creatorcontrib><creatorcontrib>Furuta, Yasuo</creatorcontrib><creatorcontrib>Kamimura, Junko</creatorcontrib><title>Composición para reducir la opacidad de la piel</title><description>Un uso no terapéutico de una composición para la reducción de la opacidad de la piel, comprendiendo la composición un adenosín-monofosfato o una sal del mismo en una proporción de 1% a 10% en peso sobre la base de la cantidad total de la composición, en el que la composición comprende además un éster de poligliceril-ácido graso, un ácido alcanoil-láctico o una sal del mismo, un copolímero de ácido acrílico-metacrilato de alquilo, agua y un aceite, y se formula en una emulsión O/W. The present invention provides a cosmetic composition that can effectively improve melasma and a cosmetic composition that can effectively reduce skin dullness. The cosmetic composition for improving melasma comprises a purine nucleic acid-related substance and a cosmetically acceptable carrier, and exhibits an excellent melasma improving effect due to the action of the purine nucleic acid-related substance contained. The cosmetic composition for reducing skin dullness comprises a purine nucleic acid-related substance and a cosmetically acceptable carrier, and exhibits an excellent effect of reducing skin dullness due to the action of the purine nucleic acid-related substance contained.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><subject>SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBwzs8tyC_OTM48vDlPoSCxKFGhKDWlNDmzSCEnUSG_IDE5MyUxRSElFcQtyEzN4WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcVADal5qSXxrsFGZsbGxiYGISHGxsSoAQCE9CvB</recordid><startdate>20170920</startdate><enddate>20170920</enddate><creator>Yoshino, Noboru</creator><creator>Tanaka, Hideo</creator><creator>Harano, Fumiki</creator><creator>Wakamatsu, Kosaburo</creator><creator>Kawamura, Mitsuaki</creator><creator>Kawabata, Shigekatsu</creator><creator>Tanaka, Masahiko</creator><creator>Shinohara, Shigeo</creator><creator>Furuta, Yasuo</creator><creator>Kamimura, Junko</creator><scope>EVB</scope></search><sort><creationdate>20170920</creationdate><title>Composición para reducir la opacidad de la piel</title><author>Yoshino, Noboru ; Tanaka, Hideo ; Harano, Fumiki ; Wakamatsu, Kosaburo ; Kawamura, Mitsuaki ; Kawabata, Shigekatsu ; Tanaka, Masahiko ; Shinohara, Shigeo ; Furuta, Yasuo ; Kamimura, Junko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2633340TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><topic>SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>Yoshino, Noboru</creatorcontrib><creatorcontrib>Tanaka, Hideo</creatorcontrib><creatorcontrib>Harano, Fumiki</creatorcontrib><creatorcontrib>Wakamatsu, Kosaburo</creatorcontrib><creatorcontrib>Kawamura, Mitsuaki</creatorcontrib><creatorcontrib>Kawabata, Shigekatsu</creatorcontrib><creatorcontrib>Tanaka, Masahiko</creatorcontrib><creatorcontrib>Shinohara, Shigeo</creatorcontrib><creatorcontrib>Furuta, Yasuo</creatorcontrib><creatorcontrib>Kamimura, Junko</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Yoshino, Noboru</au><au>Tanaka, Hideo</au><au>Harano, Fumiki</au><au>Wakamatsu, Kosaburo</au><au>Kawamura, Mitsuaki</au><au>Kawabata, Shigekatsu</au><au>Tanaka, Masahiko</au><au>Shinohara, Shigeo</au><au>Furuta, Yasuo</au><au>Kamimura, Junko</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Composición para reducir la opacidad de la piel</title><date>2017-09-20</date><risdate>2017</risdate><abstract>Un uso no terapéutico de una composición para la reducción de la opacidad de la piel, comprendiendo la composición un adenosín-monofosfato o una sal del mismo en una proporción de 1% a 10% en peso sobre la base de la cantidad total de la composición, en el que la composición comprende además un éster de poligliceril-ácido graso, un ácido alcanoil-láctico o una sal del mismo, un copolímero de ácido acrílico-metacrilato de alquilo, agua y un aceite, y se formula en una emulsión O/W. The present invention provides a cosmetic composition that can effectively improve melasma and a cosmetic composition that can effectively reduce skin dullness. The cosmetic composition for improving melasma comprises a purine nucleic acid-related substance and a cosmetically acceptable carrier, and exhibits an excellent melasma improving effect due to the action of the purine nucleic acid-related substance contained. The cosmetic composition for reducing skin dullness comprises a purine nucleic acid-related substance and a cosmetically acceptable carrier, and exhibits an excellent effect of reducing skin dullness due to the action of the purine nucleic acid-related substance contained.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language spa
recordid cdi_epo_espacenet_ES2633340TT3
source esp@cenet
subjects CHEMISTRY
DERIVATIVES THEREOF
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPECIFIC USE OF COSMETICS OR SIMILAR TOILETPREPARATIONS
SUGARS
title Composición para reducir la opacidad de la piel
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T17%3A08%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Yoshino,%20Noboru&rft.date=2017-09-20&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2633340TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true